NO920377L - Nitrogen-heterocykliske forbindelser - Google Patents
Nitrogen-heterocykliske forbindelserInfo
- Publication number
- NO920377L NO920377L NO92920377A NO920377A NO920377L NO 920377 L NO920377 L NO 920377L NO 92920377 A NO92920377 A NO 92920377A NO 920377 A NO920377 A NO 920377A NO 920377 L NO920377 L NO 920377L
- Authority
- NO
- Norway
- Prior art keywords
- nitrogen
- heterocyclic compounds
- heterocyclic
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919102807A GB9102807D0 (en) | 1991-02-11 | 1991-02-11 | Nitrogen heterocycles |
| GB919110593A GB9110593D0 (en) | 1991-05-16 | 1991-05-16 | Heterocyclic derivatives |
| GB919113183A GB9113183D0 (en) | 1991-06-18 | 1991-06-18 | Nitrogen compounds |
| GB919116314A GB9116314D0 (en) | 1991-07-29 | 1991-07-29 | Heterocyclic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO920377D0 NO920377D0 (no) | 1992-01-28 |
| NO920377L true NO920377L (no) | 1992-08-12 |
Family
ID=27450623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO92920377A NO920377L (no) | 1991-02-11 | 1992-01-28 | Nitrogen-heterocykliske forbindelser |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5236937A (ja) |
| EP (1) | EP0499415A1 (ja) |
| JP (1) | JPH0592956A (ja) |
| KR (1) | KR920016447A (ja) |
| AU (1) | AU1040992A (ja) |
| CA (1) | CA2060107A1 (ja) |
| CS (1) | CS36192A3 (ja) |
| FI (1) | FI920564A7 (ja) |
| GB (1) | GB9202585D0 (ja) |
| HU (1) | HUT60488A (ja) |
| IE (1) | IE920175A1 (ja) |
| IL (1) | IL100746A0 (ja) |
| MX (1) | MX9200559A (ja) |
| NO (1) | NO920377L (ja) |
| ZW (1) | ZW1492A1 (ja) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5284954A (en) * | 1990-09-10 | 1994-02-08 | Abbott Laboratories | Process for the preparation of tetrazoles |
| GB9121727D0 (en) * | 1991-10-14 | 1991-11-27 | Ici Plc | Heterocyclic compounds |
| US5364869A (en) * | 1992-03-09 | 1994-11-15 | Abbott Laboratories | Heterocycle-substituted benzyaminopyridine angiotensin II receptor antagonists |
| TW348175B (en) * | 1993-01-06 | 1998-12-21 | Hoechst Ag | Process for the preparation of biphenyl derivatives |
| FR2711367B1 (fr) * | 1993-10-19 | 1995-12-01 | Roussel Uclaf | Nouveau procédé de préparation de dérivés soufrés de l'imidazole et les nouveaux intermédiaires obtenus. |
| DE4320432A1 (de) * | 1993-06-21 | 1994-12-22 | Bayer Ag | Substituierte Mono- und Bipyridylmethylderivate |
| US6455734B1 (en) | 2000-08-09 | 2002-09-24 | Magnesium Diagnostics, Inc. | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
| US6521618B2 (en) | 2000-03-28 | 2003-02-18 | Wyeth | 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| EP1466904A4 (en) * | 2001-12-28 | 2005-12-14 | Takeda Pharmaceutical | BIARYL CONNECTION AND ITS USE |
| US7238717B2 (en) * | 2002-05-24 | 2007-07-03 | Millennium Pharmaceuticals, Inc. | CCR9 inhibitors and methods of use thereof |
| GB0225548D0 (en) | 2002-11-01 | 2002-12-11 | Glaxo Group Ltd | Compounds |
| WO2006078941A2 (en) * | 2005-01-20 | 2006-07-27 | Sirtris Pharmaceuticals, Inc. | Novel sirtuin activating compounds and methods of use thereof |
| KR101488812B1 (ko) * | 2005-04-12 | 2015-02-02 | 바이코어 파마 아베 | 신규한 비시클릭 안지오텐신 ⅱ 아고니스트 |
| DE602006018122D1 (de) | 2005-04-12 | 2010-12-23 | Vicore Pharma Ab | Neue tricyclische angiotensin-ii-agonisten |
| JP5202301B2 (ja) | 2005-04-12 | 2013-06-05 | ヴィコール・ファルマ・アーベー | 新規な三環系アンジオテンシンiiアゴニスト |
| AU2008261102B2 (en) | 2007-06-04 | 2013-11-28 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| HK1220611A1 (zh) | 2013-03-15 | 2017-05-12 | Bausch Health Ireland Limited | 用於治疗胃肠道病症的组成物 |
| US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
| EP3004138B1 (en) | 2013-06-05 | 2024-03-13 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0009465A1 (de) * | 1978-09-20 | 1980-04-02 | Ciba-Geigy Ag | N-(1-(4-Amino-2-chinazolinyl)-3- oder -4-piperidyl-lactame, Verfahren zu ihrer Herstellung, sowie pharmazeutische Präparate enthaltend diese Verbindungen |
| CA1334092C (en) * | 1986-07-11 | 1995-01-24 | David John Carini | Angiotensin ii receptor blocking imidazoles |
| US4820843A (en) * | 1987-05-22 | 1989-04-11 | E. I. Du Pont De Nemours And Company | Tetrazole intermediates to antihypertensive compounds |
| US5015651A (en) * | 1988-01-07 | 1991-05-14 | E. I. Du Pont De Nemours And Company | Treatment of hypertension with 1,2,4-angiotensin II antagonists |
| US4880804A (en) * | 1988-01-07 | 1989-11-14 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking benzimidazoles |
| GB8804439D0 (en) * | 1988-02-25 | 1988-03-23 | Pfizer Ltd | Dihydropyridines |
| FI903966A7 (fi) * | 1989-08-11 | 1991-02-12 | Ici Plc | Typpiyhdisteitä |
| CA2037630C (en) * | 1990-03-07 | 2001-07-03 | Akira Morimoto | Nitrogen-containing heterocylic compounds, their production and use |
| EP0453210A3 (en) * | 1990-04-19 | 1993-01-13 | Imperial Chemical Industries Plc | Pyridine derivatives |
| CN1034934C (zh) * | 1990-06-19 | 1997-05-21 | 明治制果株式会社 | 血管紧张素ii拮抗性吡啶衍生物的制备方法 |
| IE912956A1 (en) * | 1990-09-10 | 1992-03-11 | Abbott Lab | Angiotensin ii receptor antagonists |
-
1992
- 1992-01-21 IE IE017592A patent/IE920175A1/en unknown
- 1992-01-22 AU AU10409/92A patent/AU1040992A/en not_active Abandoned
- 1992-01-23 IL IL100746A patent/IL100746A0/xx unknown
- 1992-01-27 ZW ZW14/92A patent/ZW1492A1/xx unknown
- 1992-01-28 NO NO92920377A patent/NO920377L/no unknown
- 1992-01-28 CA CA002060107A patent/CA2060107A1/en not_active Abandoned
- 1992-01-29 HU HU9200268A patent/HUT60488A/hu unknown
- 1992-02-07 GB GB929202585A patent/GB9202585D0/en active Pending
- 1992-02-07 EP EP92301048A patent/EP0499415A1/en not_active Withdrawn
- 1992-02-07 CS CS92361A patent/CS36192A3/cs unknown
- 1992-02-10 KR KR1019920002019A patent/KR920016447A/ko not_active Withdrawn
- 1992-02-10 MX MX9200559A patent/MX9200559A/es unknown
- 1992-02-11 US US07/834,038 patent/US5236937A/en not_active Expired - Fee Related
- 1992-02-11 FI FI920564A patent/FI920564A7/fi unknown
- 1992-02-12 JP JP4073623A patent/JPH0592956A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CS36192A3 (en) | 1992-08-12 |
| FI920564A0 (fi) | 1992-02-11 |
| GB9202585D0 (en) | 1992-03-25 |
| JPH0592956A (ja) | 1993-04-16 |
| IE920175A1 (en) | 1992-08-12 |
| KR920016447A (ko) | 1992-09-24 |
| AU1040992A (en) | 1992-08-13 |
| EP0499415A1 (en) | 1992-08-19 |
| IL100746A0 (en) | 1992-09-06 |
| US5236937A (en) | 1993-08-17 |
| MX9200559A (es) | 1992-08-01 |
| FI920564L (fi) | 1992-08-12 |
| HU9200268D0 (en) | 1992-04-28 |
| CA2060107A1 (en) | 1992-08-12 |
| HUT60488A (en) | 1992-09-28 |
| ZW1492A1 (en) | 1992-09-30 |
| FI920564A7 (fi) | 1992-08-12 |
| NO920377D0 (no) | 1992-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI935134A7 (fi) | Substituoidut 3-aminokinuklidiinit | |
| FI925100A7 (fi) | Substituoituja bifenyylipyridoneja | |
| FI925381A0 (fi) | Signaleringsanordningar i ett centralsystem foer cellulaer mobiltelefoni | |
| FI934548L (fi) | En pappersarkmaterial foer ett aromatiskt aemne innehaollande roekningsprodukt | |
| MX9100513A (es) | Compuestos | |
| NO920377L (no) | Nitrogen-heterocykliske forbindelser | |
| FI933549A0 (fi) | Lyssnande kontrollkanal i ett cellulaert mobilradiotelefonsystem | |
| FI924956A0 (fi) | Multiplexerat elektrohydrauliskt kontrollsystem foer anvaendning i ett submarint produktionssystem | |
| MX9100517A (es) | Compuestos | |
| FI921361L (fi) | Lagerhus foer ett flerradigt rullager | |
| FI932248L (fi) | Hepatit b-vaccinkomposition innehaollande ett gallsyrasalt | |
| FI920840L (fi) | Boggie foer raelsfordon | |
| FI89570B (fi) | Axelkonstruktion foer ett nyttofordon | |
| FI925980A7 (fi) | Bisheterocykliska foereningar | |
| NO933170D0 (no) | Heterocykliske forbindelser | |
| FI915200L (fi) | Foerfarande foer olineaer signalbehandling i en ekoslaeckare | |
| FI933900L (fi) | Heterocykliska foereningar | |
| FI932996A7 (fi) | Heterocykliska foereningar | |
| FI920998L (fi) | Skaermad hytt i modulkonstruktion | |
| DK106991D0 (da) | Dichloranilinforbindelser | |
| TR25953A (tr) | SüBSTITüE EDILMIS 2-ARILPIROLLER | |
| FI930356L (fi) | Oeverfoeringsfoerfarande foer ett infraroedfjaerrstyrningssystem | |
| FI920668A7 (fi) | Oksatsinobentsatsoliyhdisteet | |
| FI940890L (fi) | Uusia yhdisteitä | |
| TR26694A (tr) | SüBSTITüE EDILMIS 4-HETARIL-PIRAZOLINLER |